The relationship between dectin-1 and mast cells in patients with diarrhea-predominant irritable bowel syndrome

References

• Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393–1407 e5.
   Web of Science ®Google Scholar
• Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712–721.e4.
   PubMed Web of Science ®Google Scholar
• Keszthelyi D, Troost FJ, Masclee AA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;303(2):G141–G154.
   PubMed Web of Science ®Google Scholar
• Chang JY, Locke GR, 3rd, McNally MA, et al. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol. 2010;105(4):822–832.
   PubMed Web of Science ®Google Scholar
• Hong SN, Rhee PL. Unraveling the ties between irritable bowel syndrome and intestinal microbiota. World J Gastroenterol. 2014;20(10):2470–2481.
   PubMed Web of Science ®Google Scholar
• Bienenstock J, Collins S. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: psycho-neuroimmunology and the intestinal microbiota: clinical observations and basic mechanisms. Clin Exp Immunol. 2010;160(1):85–91.
   PubMed Web of Science ®Google Scholar
• Enaud R, Vandenborght LE, Coron N, et al. The mycobiome: a neglected component in the microbiota-gut-brain axis. Microorganisms. 2018;6(1):22.
   Web of Science ®Google Scholar
• Wheeler ML, Limon JJ, Bar AS, et al. Immunological consequences of intestinal fungal dysbiosis. Cell Host Microbe. 2016;19(6):865–873.
   PubMed Web of Science ®Google Scholar
• Santelmann H, Howard JM. Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2005;17(1):21–26.
   PubMed Web of Science ®Google Scholar
• Wang ZK, Yang YS, Stefka AT, et al. Review article: fungal microbiota and digestive diseases. Aliment Pharmacol Ther. 2014;39(8):751–766.
   PubMed Web of Science ®Google Scholar
• Maresca M, Yahi N, Younes-Sakr L, et al. Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transepithelial passage of commensal bacteria. Toxicol Appl Pharmacol. 2008;228(1):84–92.
   PubMed Web of Science ®Google Scholar
• Chi Y, Liu XG, Wang HH, et al. The expression of mucosal IL-1beta, TNFalpha and serotonin transporter in chronic visceral hypersensitivity rats. Zhonghua Nei Ke Za Zhi. 2010;49:781–784.
   PubMedGoogle Scholar
• Piliponsky AM, Romani L. The contribution of mast cells to bacterial and fungal infection immunity. Immunol Rev. 2018;282(1):188–197.
   PubMed Web of Science ®Google Scholar
• Urb M, Pouliot P, Gravelat FN, et al. Aspergillus fumigatus induces immunoglobulin E-independent mast cell degranulation. J Infect Dis. 2009;200(3):464–472.
   PubMed Web of Science ®Google Scholar
• Romo-Lozano Y, Hernández-Hernández F, Salinas E. Mast cell activation by conidia of Sporothrix schenckii: role in the severity of infection. Scand J Immunol. 2012;76(1):11–20.
   PubMed Web of Science ®Google Scholar
• Selander C, Engblom C, Nilsson G, et al. TLR2/MyD88-dependent and -independent activation of mast cell IgE responses by the skin commensal yeast malassezia sympodialis. J Immunol. 2009;182(7):4208–4216.
   PubMed Web of Science ®Google Scholar
• Romo-Lozano Y, Hernández-Hernández F, Salinas E. Sporothrix schenckii yeasts induce ERK pathway activation and secretion of IL-6 and TNF-α in rat mast cells, but no degranulation. Med Mycol. 2014;52(8):862–868.
   PubMed Web of Science ®Google Scholar
• Lopes JP, Stylianou M, Nilsson G, et al. Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells. Sci Rep. 2015;5:12287
   PubMed Web of Science ®Google Scholar
• Nieto-Patlán A, Campillo-Navarro M, Rodríguez-Cortés O, et al. Recognition of Candida albicans by dectin-1 induces mast cell activation. Immunobiology. 2015;220(9):1093–1100.
   PubMed Web of Science ®Google Scholar
• Botschuijver S, Roeselers G, Levin E, et al. Intestinal fungal dysbiosis is associated with visceral hypersensitivity in patients with irritable bowel syndrome and rats. Gastroenterology. 2017;153(4):1026–1039.
   PubMed Web of Science ®Google Scholar
• Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature. 2001;413(6851):36–37.
   PubMed Web of Science ®Google Scholar
• Iliev ID, Funari VA, Taylor KD, et al. Interactions between commensal fungi and the C-type lectin receptor dectin-1 influence colitis. Science. 2012;336(6086):1314–1317.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Chihara K, Honjoh C, et al. Dectin-1-mediated signaling leads to characteristic gene expressions and cytokine secretion via spleen tyrosine kinase (Syk) in rat mast cells. J Biol Chem. 2014;289(45):31565–31575.
   PubMed Web of Science ®Google Scholar
• Rasijeff AMP, Withers M, Burke JM, et al. High-resolution anorectal manometry: a comparison of solid-state and water-perfused catheters. Neurogastroenterol Motil. 2017;29(11):e13124.
   Web of Science ®Google Scholar
• Lee TH, Bharucha AE. How to perform and interpret a high-resolution anorectal manometry test. J Neurogastroenterol Motil. 2016;22(1):46–59.
   PubMed Web of Science ®Google Scholar
• Rao SS. Advances in diagnostic assessment of fecal incontinence and dyssynergic defecation. Clin Gastroenterol Hepatol. 2010;8(11):910–919.
   PubMed Web of Science ®Google Scholar
• Qin L, Qin J, Yang Q, et al. Efficacy and safety of pinaverium bromide combined with flupentixol-melitracen for diarrhea-type irritable bowel syndrome: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(2):e14064.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Xiong L, Li L, et al. Alterations of gut microbiota in patients with irritable bowel syndrome: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2017;32(1):28–38.
   PubMed Web of Science ®Google Scholar
• Richard ML, Lamas B, Liguori G, et al. Gut fungal microbiota: the Yin and Yang of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(3):656–665.
   PubMed Web of Science ®Google Scholar
• Olynych TJ, Jakeman DL, Marshall JS. Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism. J Allergy Clin Immunol. 2006;118(4):837–843.
   PubMed Web of Science ®Google Scholar
• Barbara G, Stanghellini V, De Giorgio R, et al. Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil. 2006;18(1):6–17.
   PubMed Web of Science ®Google Scholar
• Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126(3):693–702.
   PubMed Web of Science ®Google Scholar
• Park JH, Rhee P-L, Kim HS, et al. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol Hepatol. 2006;21(1):71–78.
   PubMed Web of Science ®Google Scholar
• Barbara G, Wang B, Stanghellini V, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132(1):26–37.
   PubMed Web of Science ®Google Scholar
• La JH, Kim TW, Sung TS, et al. Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome. J Vet Sci. 2004;5(4):319–324.
   PubMedGoogle Scholar
• Ohashi K, Sato Y, Iwata H, et al. Colonic mast cell infiltration in rats with TNBS-induced visceral hypersensitivity. J Vet Med Sci. 2007;69(12):1223–1228.
   PubMed Web of Science ®Google Scholar
• Cenac N, Andrews CN, Holzhausen M, et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest. 2007;117(3):636–647.
   PubMed Web of Science ®Google Scholar
• Gu Y, Zhou G, Qin X, et al. The potential role of gut mycobiome in irritable bowel syndrome. Front Microbiol. 2019;10:1894.
   PubMed Web of Science ®Google Scholar